Cancer screening programs in Japan: Progress and challenges
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Japan offers national cancer screening programs, but participation rates for breast and cervical cancers lag behind OECD averages. Enhancing evidence-based guidelines and quality assurance is crucial for improving screening effectiveness.
Area Of Science
- Public Health
- Oncology
- Health Services Research
Background
- Japan has established national screening programs for major cancers including gastric, colorectal, lung, breast, and cervical cancers.
- Cancer screening guidelines have been developed and updated since 2003, promoting evidence-based practices.
- Current screening delivery primarily occurs through community and workplace initiatives.
Purpose Of The Study
- To evaluate the current state of national cancer screening programs in Japan.
- To identify challenges and areas for improvement in cancer screening delivery and participation.
- To highlight the need for enhanced evidence-based practices and quality assurance systems.
Main Methods
- Analysis of existing national screening programs and guidelines for various cancers.
- Comparison of participation rates with Organisation for Economic Co-operation and Development (OECD) countries.
- Assessment of data collection methods for participation rates, including reliance on surveys due to lack of national registries.
- Review of quality assurance systems for community and workplace screening.
Main Results
- Participation rates for breast and cervical cancer screening are lower compared to the OECD average.
- Accurate calculation of participation rates is hindered by the absence of comprehensive national cancer screening registries.
- Quality assurance systems were historically limited to community-based screening and only recently adapted for workplace settings.
Conclusions
- The complex delivery system of cancer screening programs may impede higher participation rates.
- Continued efforts are required to strengthen evidence-based screening recommendations.
- Establishing a robust and comprehensive national quality assurance system is essential for improving cancer screening effectiveness in Japan.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
• Adult screening for blood pressure, cholesterol, and diabetes
• Cancer screenings such as colonoscopies and...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...